Follow the Neurotech International Limited stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, Neurotech International Limited has published 4 public disclosures. Market capitalisation: €21m. The latest transaction was reported on 8 September 2026 (Other). Among the most active insiders: Andrew Chapman Date of appointment 8 September 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Neurotech International Limited es una empresa centrada en el desarrollo de soluciones terapéuticas basadas en tecnología para trastornos neurológicos. Cotiza en el mercado XASX.